🇺🇸 FDA
Patent

US 6759538

Substituted diphenyl heterocycles useful for treating HCV infection

expired A61PA61P31/12A61P31/14

Quick answer

US patent 6759538 (Substituted diphenyl heterocycles useful for treating HCV infection) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P31/12, A61P31/14, A61P43/00